AmeriFlex Group’s Exact Sciences EXAS Stock Holding History

AmeriFlex Group’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13	Closed	-$674	–	1152
2025 Q2	$674	Hold	13	–	–	﹤0.01%	1018
2025 Q1	$563	Buy	+13	New	+$658	﹤0.01%	1231

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AmeriFlex Group's EXAS Position: Q3 2025 in Review

AmeriFlex Group sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 13 shares — an estimated $674 sold.

AmeriFlex Group first reported a position in EXAS in Q1 2025 and held it in 2 quarters. The position peaked at $674 in Q2 2025. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

AmeriFlex Group reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
AmeriFlex Group sold 13 Exact Sciences shares in Q3 2025, an estimated $674.
AmeriFlex Group first reported a position in Exact Sciences in Q1 2025 and held it in 2 quarters.
AmeriFlex Group's Exact Sciences position peaked at $674 in Q2 2025.
567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on AmeriFlex Group's 13F filing for Q3 2025, filed 12 Nov 2025.